Skip to main content

Table 1 Patient characteristics

From: Changes in serum indoxyl sulfate levels after acute myocardial infarction and the correlation with kidney injury: an observational study

  (n = 20)
Age (years) 68 ± 12
Sex (male/female) 15/5
Smoking (%) 12 (60)
History of CVD (%) 3 (15)
Diabetes mellitus (%) 12 (60)
Systolic blood pressure (mmHg) 126.9 ± 24.3
Diastolic blood pressure (mmHg) 74.4 ± 15.3
eGFR (mL/min/1.73 m2) 71.6 ± 25.1
Indoxyl sulfate (μg/mL) 0.56 [0.32–0.93]
Max CK (U/L) 1924.0 [719.5–3067.0]
Max CK-MB (U/L) 207.5 [74.3–300.0]
NT-pro BNP (pg/mL) 159.0 [33.3–1610.0]
Dose of contrast media (mL) 190.7 ± 52.5
LVEF (%) 53.1 ± 11.3
Antiplatelet agent (%) 1 (5)
Statin (%) 4 (20)
Ca-blocker (%) 4 (20)
RAS-I (%) 5 (25)
β-blocker (%) 0 (0)
  1. BMI body mass index, CVD cardiovascular disease, eGFR estimated glomerular filtration rate, CK creatine kinase, NT-pro BNP N-terminal pro-B-type natriuretic peptide, LVEF left ventricular ejection fraction, Ca-blocker calcium channel blocker, RAS-I renin-angiotensin system inhibitor